West Pharmaceutical Services, Inc.
WST
Rang in aandelen
#878
West Pharmaceutical Services, Inc. (WST) specializes in the development,... West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Aandeelprijs
$389.10
Marktkapitalisatie
$27.38B
Verandering (1 dag)
1.30%
Verandering (1 jaar)
41.54%
Land
US
Handel West Pharmaceutical Services, Inc. (WST)
Categorie
Healthcare
Winst voor West Pharmaceutical Services, Inc. (WST)
Winst in Jun 2026 TTM: $699.60M
Volgens de meest recente financiële verslagen van West Pharmaceutical Services, Inc. bedraagt de huidige winst van het bedrijf $699.60M. In 2024 behaalde het bedrijf een winst van $600.20M, een daling ten opzichte van de winst van 2023, die $715.70M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van West Pharmaceutical Services, Inc. van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $699.60M | 16.43% |
| 2025 | $600.90M | 0.12% |
| 2024 | $600.20M | -16.14% |
| 2023 | $715.70M | 2.16% |
| 2022 | $700.60M | -8.89% |
| 2021 | $769.00M | 83.66% |
| 2020 | $418.70M | 39.24% |
| 2019 | $300.70M | 21.10% |
| 2018 | $248.30M | 7.21% |
| 2017 | $231.60M | 16.97% |
| 2016 | $198.00M | 62.43% |
| 2015 | $121.90M | -30.06% |
| 2014 | $174.30M | 14.30% |
| 2013 | $152.50M | 34.48% |
| 2012 | $113.40M | 14.55% |
| 2011 | $99.00M | 25.48% |
| 2010 | $78.90M | -8.36% |
| 2009 | $86.10M | -21.94% |
| 2008 | $110.30M | 24.07% |
| 2007 | $88.90M | 2.89% |
| 2006 | $86.40M | 35.42% |
| 2005 | $63.80M | 54.85% |
| 2004 | $41.20M | -12.34% |
| 2003 | $47.00M | 173.26% |
| 2002 | $17.20M | -38.13% |
| 2001 | $27.80M | 796.77% |
| 2000 | $3.10M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $3.81B | 444.00% |
US
|
|
| $4.11B | 487.31% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 127.27% |
US
|
|
| - | - |
CH
|
